宜明昂科-B(01541)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01541 宜明昂科-B

未开盘 12-22 16:08:10

6.330

+0.090

+1.44%

最高6.500	最低6.150	成交量90.22万
今开6.270	昨收6.240	日振幅5.61%
总市值27.35亿	流通市值26.59亿	总股本4.32亿
成交额571.09万	换手率0.21%	流通股本4.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01541","market":"HK","secType":"STK","nameCN":"宜明昂科-B","latestPrice":6.33,"timestamp":1766390890004,"preClose":6.24,"halted":0,"volume":902200,"delay":0,"floatShares":420000000,"shares":432000000,"eps":-0.9265277654239343,"marketStatus":"未开盘","change":0.09,"latestTime":"12-22 16:08:10","open":6.27,"high":6.5,"low":6.15,"amount":5710872,"amplitude":0.05609,"askPrice":6.39,"askSize":2000,"bidPrice":6.33,"bidSize":6800,"shortable":3,"etf":0,"ttmEps":-0.8505052410724009,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766453400000},"marketStatusCode":0,"adr":0,"listingDate":1693843200000,"exchange":"SEHK","adjPreClose":6.24,"openAndCloseTimeList":[[1766367000000,1766376000000],[1766379600000,1766390400000]],"volumeRatio":1.339132,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01541","defaultTab":"news","newsList":[{"id":"2592163413","title":"宜明昂科-B12月19日主力净流入59.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2592163413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592163413?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:15","pubTimestamp":1766132126,"startTime":"0","endTime":"0","summary":"12月19日, 宜明昂科-B股价涨3.14%，报收6.24元，成交金额363.2万元，换手率0.14%，振幅4.30%，量比0.90。宜明昂科-B今日主力资金净流入59.3万元，上一交易日主力净流出0万元。该股近5个交易日下跌4.00%，主力资金累计净流出81.6万元；近20日主力资金累计净流出571.4万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161706a45f1fa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219161706a45f1fa1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2592153445","title":"港股异动 | 宜明昂科-B(01541)涨近4% 自研阿沐瑞芙普α皮下制剂IMM0306S临床研究申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2592153445","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592153445?lang=zh_cn&edition=full","pubTime":"2025-12-19 14:13","pubTimestamp":1766124833,"startTime":"0","endTime":"0","summary":"消息面上，据宜明昂科官微消息，12月18日，公司宣布，自主研发的、同时靶向CD47和CD20的双特异性抗体-受体重组蛋白药物阿沐瑞芙普αIMM0306S用于治疗系统性红斑狼疮的临床试验申请已正式获得国家药品监督管理局受理。IMM0306S是基于宜明昂科核心产品阿沐瑞芙普α开发的皮下制剂。值得一提的是，在第67届美国血液学会年会上，宜明昂科公布了阿沐瑞芙普α联合来那度胺治疗复发/难治性CD20阳性滤泡性淋巴瘤的I/II期临床研究数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1383572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2592163459","title":"宜明昂科阿沐瑞芙普α皮下制剂IMM0306S临床研究申请获受理，系统性红斑狼疮治疗迎新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2592163459","media":"抗体圈","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592163459?lang=zh_cn&edition=full","pubTime":"2025-12-19 11:07","pubTimestamp":1766113634,"startTime":"0","endTime":"0","summary":"研究显示， IMM0306在治疗中至重度活动性SLE患者中展现出显著疗效和良好安全性。IMM0306S通过皮下注射方式给药，可显著降低血药浓度峰值并有效减少靶向血液毒性及脱靶效应，以进一步提高药物疗效。宜明昂科计划在III期临床试验中进一步验证IMM0306的疗效和安全性，以期为患者提供更安全有效的治疗方案。系统性红斑狼疮是一种严重的自身免疫性疾病，目前临床仍存在巨大未满足需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219111710a45e1b15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219111710a45e1b15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2592911679","title":"每日卖空追踪 | 宜明昂科-B 12月17日卖空量成交1.16万股，卖空比例为1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592911679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592911679?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:30","pubTimestamp":1765960221,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间12月17日，跌1.3%，卖空量成交1.16万股，较上一交易日减少71.71%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163307a6ad2400&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217163307a6ad2400&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2592931390","title":"2026年一个注定燃爆的BD方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2592931390","media":"药渡Daily","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592931390?lang=zh_cn&edition=full","pubTime":"2025-12-16 17:30","pubTimestamp":1765877458,"startTime":"0","endTime":"0","summary":"司美格鲁肽原研由诺和诺德开发，但随着其核心专利将于2026年3月到期，中国市场正在上演激烈的司美格鲁肽生物类似药争夺战。截至目前，国内已有10款国产司美格鲁肽申报上市，并有10款已进入临床III期阶段。展望减重领域的下一个BD热点，三靶点GLP-1或是其中之一。全球口服小分子GLP-1R激动剂研发管线（部分）图源：国金证券研报展望2026年，减脂不减肌药物、小核酸减重药物有望成为下一个BD“金矿”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216184301a6a93b82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216184301a6a93b82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1161","06887","BK1515","01541","BK1574","02105"],"gpt_icon":0},{"id":"2592937580","title":"每日卖空追踪 | 宜明昂科-B 12月16日卖空量成交3.94万股，卖空比例为6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592937580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592937580?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:30","pubTimestamp":1765873820,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间12月16日，跌0.81%，卖空量成交3.94万股，较上一交易日增加126.44%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163303a6a8b4d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216163303a6a8b4d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2592375879","title":"宜明昂科-B12月16日遭主力抛售21.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592375879","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592375879?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:15","pubTimestamp":1765872940,"startTime":"0","endTime":"0","summary":"12月16日, 宜明昂科-B股价跌0.81%，报收6.16元，成交金额370.5万元，换手率0.15%，振幅3.86%，量比0.72。宜明昂科-B今日主力资金净流出21.8万元，上一交易日主力净流出110.0万元。该股近5个交易日下跌4.64%，主力资金累计净流出113.3万元；近20日主力资金累计净流出209.6万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216161904a6a8a413&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216161904a6a8a413&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2590024313","title":"每日卖空追踪 | 宜明昂科-B 12月10日卖空量成交1.04万股，卖空比例为1.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590024313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590024313?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:30","pubTimestamp":1765355422,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间12月10日，涨3.87%，卖空量成交1.04万股，较上一交易日减少71.27%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016331495353c99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121016331495353c99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2590302455","title":"宜明昂科-B12月10日主力净流入0.1万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2590302455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590302455?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:15","pubTimestamp":1765354537,"startTime":"0","endTime":"0","summary":"12月10日, 宜明昂科-B股价涨3.87%，报收6.71元，成交金额670.8万元，换手率0.24%，振幅6.19%，量比1.45。宜明昂科-B今日主力资金净流入0.1万元，上一交易日主力净流出266.1万元。该股近5个交易日上涨4.69%，主力资金累计净流出330.0万元；近20日主力资金累计净流入530.0万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210161824a43f943d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210161824a43f943d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2590335264","title":"每日卖空追踪 | 宜明昂科-B 12月08日卖空量成交800股，卖空比例为0.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590335264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590335264?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:30","pubTimestamp":1765182621,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间12月08日，跌3.74%，卖空量成交800股，较上一交易日减少97.22%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163311a43af9c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163311a43af9c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2590352641","title":"宜明昂科-B12月08日主力净流出64.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2590352641","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590352641?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:15","pubTimestamp":1765181745,"startTime":"0","endTime":"0","summary":"12月08日, 宜明昂科-B股价跌3.74%，报收6.44元，成交金额276.7万元，换手率0.10%，振幅4.33%，量比0.50。宜明昂科-B今日主力资金净流出64.0万元，上一交易日主力净流出0万元。该股近5个交易日下跌5.98%，主力资金累计净流出157.5万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入817.5万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208161933a72aa5cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208161933a72aa5cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"1195121793","title":"宜明昂科生物（01541）更新11月股份变动月报表，注册股本增至4.31亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=1195121793","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195121793?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:01","pubTimestamp":1764838891,"startTime":"0","endTime":"0","summary":"宜明昂科生物医药技术（上海）股份有限公司于2025年12月4日发布2025年11月股份变动月报表。报告显示，公司本期在中国相关登记机关完成新增24,200,000股H股的注册手续，使注册股本从396,277,305股增至420,477,305股。整体而言，截至2025年11月30日，公司注册股本总计人民币431,507,695元，对应431,507,695股，包括420,477,305股已上市流通的H股与11,030,390股非上市股份。截至本月底，已发行股份总数保持稳定，库存股份余额为零。公司方面确认已遵守香港联交所上市规则及相关法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541"],"gpt_icon":0},{"id":"1194243102","title":"宜明昂科-B - 首席执行官以每股平均价格6.6258港元购买50,000股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=1194243102","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194243102?lang=zh_cn&edition=full","pubTime":"2025-12-03 18:06","pubTimestamp":1764756393,"startTime":"0","endTime":"0","summary":"宜明昂科-B - 首席执行官以每股平均价格6.6258港元购买50,000股H股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2588012098","title":"宜明昂科-B(01541)获执行董事田文志增持5万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588012098","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588012098?lang=zh_cn&edition=full","pubTime":"2025-12-03 18:05","pubTimestamp":1764756355,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B(01541)发布公告，董事会获田文志(田博士)告知，其已于2025年12月3日于公开市场购买合共5万股本公司H股，每股股份平均价格为约6.6258港元，占本公司已发行股份总数的约0.01%。紧随购买后，田博士于合共1.16亿股股份中拥有权益，占于本公告日期本公司已发行股本总额的26.91%。田博士表示，其对本集团的整体发展前景及潜在增长充满信心。在遵守适用法律及监管规定的情况下，田博士不排除在适当时候进一步增持本公司股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377129.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2588402682","title":"每日卖空追踪 | 宜明昂科-B 12月03日卖空量成交2.32万股，卖空比例为2.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588402682","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588402682?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:30","pubTimestamp":1764750620,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间12月03日，涨1.11%，卖空量成交2.32万股，较上一交易日减少31.36%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120316330395286e72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120316330395286e72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2588743847","title":"每日卖空追踪 | 宜明昂科-B 12月01日卖空量成交400股，卖空比例为0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588743847","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588743847?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:30","pubTimestamp":1764577822,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间12月01日，跌5.38%，卖空量成交400股，较上一交易日减少99%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116325395244820&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120116325395244820&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2588747190","title":"宜明昂科-B盘中异动 股价大跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588747190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588747190?lang=zh_cn&edition=full","pubTime":"2025-12-01 13:04","pubTimestamp":1764565443,"startTime":"0","endTime":"0","summary":"2025年12月01日下午盘13时04分，宜明昂科-B股票出现波动，股价快速下跌5.38%。截至发稿，该股报6.860港元/股，成交量21.26万股，换手率0.05%，振幅5.38%。资金方面，该股资金流入53.2414万港元，流出83.3834万港元。宜明昂科-B股票所在的生物技术行业中，整体跌幅为1.73%。其相关个股中，中生北控生物科技、维升药业-B、华领医药-B涨幅较大，振幅较大的相关个股有华昊中天医药-B、银诺医药-B、中生北控生物科技，振幅分别为16.23%、15.93%、14.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201130403a71c0ac5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201130403a71c0ac5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2586222227","title":"每日卖空追踪 | 宜明昂科-B 11月27日卖空量成交2.04万股，卖空比例为0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586222227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586222227?lang=zh_cn&edition=full","pubTime":"2025-11-27 16:30","pubTimestamp":1764232220,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间11月27日，涨6.65%，卖空量成交2.04万股，较上一交易日增加27.5%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112716353597826380&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112716353597826380&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2586219474","title":"港股异动 | 宜明昂科-B(01541)午后涨超9% IMM0306的III期临床研究方案获CDE许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2586219474","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586219474?lang=zh_cn&edition=full","pubTime":"2025-11-27 13:52","pubTimestamp":1764222736,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，宜明昂科-B(01541)午后涨超9%，截至发稿，涨7.98%，报7.31港元，成交额1070.04万港元。消息面上，宜明昂科午间公告，公司已获得国家药监局药品审评中心批准IMM0306联合来那度胺治疗复发/难治性滤泡性淋巴瘤的III期临床研究方案，标志着复发/难治性滤泡性淋巴瘤创新疗法的发展加速。据悉，IMM0306是全球首个进入临床阶段的CD47和CD20双靶向双特异性分子，可阻断“别吃我”信号，激活巨噬细胞和NK细胞，优先结合CD20而非CD47，有效消除恶性B细胞，同时将毒性降至最低，从而可改善治疗效果。公司拥有IMM0306的全球知识产权及商业化权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374362.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4017","BK4134","01541","LU1223082519.USD","LU1223082196.USD","LU1223083913.SGD","CDE","III","BK1161"],"gpt_icon":0},{"id":"2586215237","title":"宜明昂科-B(01541)：药品审评中心批准IMM0306治疗复发╱难治性滤泡性淋巴瘤的III期临床研究方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2586215237","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586215237?lang=zh_cn&edition=full","pubTime":"2025-11-27 12:33","pubTimestamp":1764218031,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B 公布，公司已获得国家药品监督管理局药品审评中心批准IMM0306联合来那度胺治疗复发╱难治性滤泡性淋巴瘤的III期临床研究方案，标志着复发╱难治性滤泡性淋巴瘤创新疗法的发展加速。据悉，由该集团独立研发的IMM0306是一种靶向分化簇47及分化簇20 的双特异性分子，是全球首个进入临床阶段的CD47和CD20双靶向双特异性分子。截至本公告日期，该集团拥有IMM0306的全球知识产权及商业化权利。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","01541","BK1161","BK4134"],"gpt_icon":0}],"profile":{"websiteUrl":"http://immuneonco.com","stockEarnings":[{"period":"1week","weight":0.0193},{"period":"1month","weight":-0.0759},{"period":"3month","weight":-0.4658},{"period":"6month","weight":-0.5248},{"period":"1year","weight":0.2584},{"period":"ytd","weight":0.2267}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0231},{"period":"3month","weight":-0.0137},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3084},{"period":"ytd","weight":0.2862}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"宜明昂科生物医药技术（上海）股份有限公司是一家主要从事开发肿瘤免疫疗法的中国公司。该公司的主要业务包括开发用于系统利用先天性和适应性免疫的生物技术，以及开发下一代肿瘤免疫疗法，免疫疗法主要专注于适应性免疫系统。该公司主要在中国国内和海外市场开展业务。","exchange":"SEHK","name":"宜明昂科-B","nameEN":"IMMUNEONCO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"宜明昂科-B(01541)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供宜明昂科-B(01541)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"宜明昂科-B,01541,宜明昂科-B股票,宜明昂科-B股票老虎,宜明昂科-B股票老虎国际,宜明昂科-B行情,宜明昂科-B股票行情,宜明昂科-B股价,宜明昂科-B股市,宜明昂科-B股票价格,宜明昂科-B股票交易,宜明昂科-B股票购买,宜明昂科-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"宜明昂科-B(01541)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供宜明昂科-B(01541)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}